The FDA said Eli Lilly’s weight-loss drugs were no longer in shortage on Oct. 2, preventing pharmacies from making cheaper ...
One person who wanted to try the drug said it took a lot of convincing. They wrote: "I went to my doctor and was in tears ...
Facing a lawsuit, the Food and Drug Administration has decided to reconsider its decision to take popular weight-loss and diabetes drugs off of the national shortage list, which will allow compounding ...
"Additionally, GLP-1 agonists can cause gastrointestinal side effects like nausea, vomiting, and diarrhoea. These symptoms ...
“The launch of GLP-1 injections has significantly ... the only options when it comes to weight loss or diabetes, and significantly more affordable FDA-approved options do exist.